Catalent (CTLT) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Catalent, Inc. Reports Second Quarter Fiscal Year 2017 Results
February 6, 2017 4:15 PM ESTQ2'17 revenue $483.7 million increased 6% as-reported, or 10% in constant currency from the prior year period. Q2'17 YTD revenue $925.9 million increased 5% as-reported, or 9% in constant currency from the prior year period. Announced the acquisition of Accucaps, a Canadian developer and manufacturer of over-the-counter (OTC) and prescription softgel products. Issued 380 million, 4.75% coupon, Euro notes with proceeds used to pay down debt and fund acquisitions; simultaneous re-price of our USD (50 bps rate reduction) and EUR (75 bps rate reduction) Term Loans.... More
